Skip to main navigation Skip to search Skip to main content

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins

  • AUTHOR GROUP

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Statins effectively lower LDL cholesterol levels in large studies and the observed interindividual response variability may be partially explained by genetic variation. Here we perform a pharmacogenetic meta-analysis of genome-wide association studies (GWAS) in studies addressing the LDL cholesterol response to statins, including up to 18,596 statin-treated subjects. We validate the most promising signals in a further 22,318 statin recipients and identify two loci, SORT1/CELSR2/PSRC1 and SLCO1B1, not previously identified in GWAS. Moreover, we confirm the previously described associations with APOE and LPA. Our findings advance the understanding of the pharmacogenetic architecture of statin response
Original languageEnglish
Pages (from-to)5068
JournalNature communications
Volume5
DOIs
Publication statusPublished - 2014

Fingerprint

Dive into the research topics of 'Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins'. Together they form a unique fingerprint.

Cite this